The numbers of TILs per gram tumor secreting GzmB, IFNγ, TNFα, and IL-2 were considerably higher in both primary and secondary tumor in the hRT/lena treatment group (Figure 6A-C). The gene discussed is IL2; the disease is neoplasm.